The effect of dextrin-rhEGF on the healing of full-thickness, excisional wounds in the (db/db) diabetic mouse

Journal of Controlled Release

Volumn 152, Issue 3, 2011, Pages 411-417

  Hardwicke, Joseph T ^a   Hart, Jeff ^b   Bell, Andrea ^b   Duncan, Ruth ^c   Thomas, David W ^a   Moseley, Ryan ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b Cica Biomedical Ltd   (United Kingdom)

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

(db db) diabetic mouse; Dextrin rhEGF conjugate; Nanomedicine; Polymer therapeutics; PUMPT; Wound repair

Indexed keywords

DEXTRIN-RHEGF CONJUGATE; DIABETIC MICE; NANOMEDICINES; POLYMER THERAPEUTICS; PUMPT; WOUND REPAIR;

AMYLASES; CELL CULTURE; GRANULATION; MAMMALS; MEDICAL NANOTECHNOLOGY; TISSUE;

REPAIR;

AMYLASE; CD31 ANTIGEN; DEXTRIN; RECOMBINANT EPIDERMAL GROWTH FACTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME BLOOD LEVEL; EPITHELIZATION; EXCISION; FIBROBLAST; GRANULATION TISSUE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; KERATINOCYTE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN; SKIN INJURY; TISSUE REGENERATION; WOUND CLOSURE; WOUND CONTRACTION; WOUND HEALING; WOUND HEALING IMPAIRMENT;

ALPHA-AMYLASES; ANIMALS; DEXTRINS; DIABETES COMPLICATIONS; DRUG CARRIERS; EPIDERMAL GROWTH FACTOR; GRANULATION TISSUE; HUMANS; MALE; MICE; MICE, MUTANT STRAINS; NEOVASCULARIZATION, PHYSIOLOGIC; RECOMBINANT PROTEINS; SKIN; WOUND HEALING;

EID: 79958238832     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2011.03.016     Document Type: Article

References (42)

1. J.R. Mekkes, M.A.M. Loots, A.C. Van der Wal, and J.D. Bos Causes, investigation and treatment of leg ulceration Br. J. Dermatol. 148 2003 388 401 (Pubitemid 36461316)
2. M.S. Agren, W.H. Eaglstein, M.W. Ferguson, K.G. Harding, K. Moore, U.K. Saarialho-Kere, and G.S. Schultz Causes and effects of the chronic inflammation in venous leg ulcers Acta Derm. Venereol. Suppl. 210 2000 3 17
3. R. Goldman Growth factors and chronic wound healing: past, present and future Adv. Skin Wound Care 17 2004 24 35
4. R. Blakytny, and E. Jude The molecular biology of chronic wounds and delayed healing in diabetes Diabet. Med. 23 2006 594 608 (Pubitemid 43830059)
5. J. Li, J. Chen, and R. Kirsner Pathophysiology of acute wound healing Clin. Dermatol. 25 2007 9 18 (Pubitemid 46177460)
6. D.R. Yager, S.M. Chen, S.I. Ward, O.O. Olutoye, R.F. Diegelmann, and I.K. Cohen Ability of chronic wound fluids to degrade peptide growth factors is associated with increased levels of elastase activity and diminished levels of proteinase inhibitors Wound Rep. Regen. 5 1997 23 32 (Pubitemid 127686717)
7. M. Wlaschek, and K. Scharffetter-Kochanek Oxidative stress in chronic venous leg ulcers Wound Rep. Regen. 13 2005 452 461 (Pubitemid 41783163)
8. S.P. Bennett, G.D. Griffiths, A.M. Schor, G.P. Leese, and S.L. Schor Growth factors in the treatment of diabetic foot ulcers Br. J. Surg. 90 2003 133 146 (Pubitemid 36237887)
9. J.M. Smiell, T.J. Wieman, D.L. Steed, B.H. Perry, A.R. Sampson, and B.H. Schwab Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with non-healing, lower extremity diabetic ulcers: a combined analysis of four randomized studies Wound Rep. Regen. 7 1999 335 346 (Pubitemid 29523009)
10. Update of Safety Review: Follow-up to the March 27, 2008, Communication about the Ongoing Safety Review of Regranex (Becaplermin). June 6, 2008 http://www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsandProviders/ DrugSafetyInformationforHeathcareProfessionals/ucm072121.htm
11. D.G. Greenhalgh, K.H. Sprugel, M.J. Murray, and R. Ross PDGF and FGF stimulate wound healing in the genetically diabetic mouse Am. J. Pathol. 136 1990 1235 1246 (Pubitemid 20210322)
12. V. Falanga, W.H. Eaglstein, B. Bucalo, M.H. Katz, B. Harris, and P. Carson Topical use of human recombinant epidermal growth factor (h-EGF) in venous ulcers J. Derm. Surg. Oncol. 18 1992 604 606
13. R.L. Brown, M.P. Breeden, and D.G. Greenhalgh PDGF and TGF-α act synergistically to improve wound healing in the genetically diabetic mouse J. Surg. Res. 56 1994 562 570 (Pubitemid 24222406)
14. R.D. Galiano, O.M. Tepper, C.R. Pelo, K.A. Bhatt, M. Callaghan, N. Bastidas, S. Bunting, H.G. Steinmetz, and G.C. Gurtner Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis by mobilizing and recruiting bone-marrow-derived cells Am. J. Pathol. 164 2004 1935 1947 (Pubitemid 38669343)
15. M.N. Khan, and C.G. Davies Advances in the management of leg ulcers - the potential role of growth factors Int. Wound J. 3 2006 113 120 (Pubitemid 44400782)
16. R. Duncan R, H.R.P. Gilbert, R.J. Carbajo, and M.J. Vicent Polymer masked-unmasked protein therapy (PUMPT) 1. Bioresponsive dextrin-trypsin and -MSH conjugates designed for α-amylase activation Biomacromolecules 9 2008 1146 1154 (Pubitemid 351639566)
17. J. Hardwicke, E.L. Ferguson, R. Moseley, P. Stephens, D.W. Thomas, and R. Duncan Dextrin-rhEGF conjugates as bioresponsive nanomedicines for wound repair J. Control. Release 130 2008 275 283
18. J. Hardwicke, R. Moseley, P. Stephens, K. Harding, R. Duncan, and D.W. Thomas Promotion of acute and chronic wound healing by bioresponsive dextrin-rhEGF polymer conjugates Mol. Pharm. 7 2010 699 707
19. J. Hardwicke, B. Song, R. Moseley, and D.W. Thomas Investigation of the potential of polymer therapeutics in corneal re-epithelialisation Br. J. Opthalmol. 94 2010 1566 1570
20. S.R. Sullivan, R.A. Underwood, N.S. Gibran, R.O. Sigle, M.L. Usui, W.G. Carter, and J.E. Olerud Validation of a model for the study of multiple wounds in the diabetic mouse (db/db) Plast. Reconstr. Surg. 113 2004 953 960 (Pubitemid 39195758)
21. T. Kawanabe, T. Kawakami, Y. Yatomi, S. Shimida, and Y. Soma Sphingosine 1-phosphate accelerates wound healing in diabetic mice J. Dermatol. Sci. 48 2007 53 60 (Pubitemid 47284808)
22. V.I. Tkalcević, S. Cuzić, M.J. Parnham, I. Pasalić, and K. Brajsa K Differential evaluation of excisional non-occluded wound healing in db/db mice Toxicol. Pathol. 37 2009 183 192
23. F. Gao, Y. Liu, Y. He, C. Yang, Y. Wang, X. Shi, and G. Wei Hyaluronan oligosaccharides promote excisional wound healing through enhanced angiogenesis Matrix Biol. 29 2010 107 116
24. D. Hreczuk-Hirst, D. Chicco, L. German, and R. Duncan Dextrins as potential carriers for drug targeting: tailored rates of dextrin degradation by introduction of pendant groups Int. J. Pharm. 230 2001 57 66 (Pubitemid 32973859)
25. S.M. Albelda, W.A. Muller, C.A. Buck, and P.J. Newman Molecular and cellular properties of PECAM-1 (endoCAM/CD31): a novel vascular cell-cell adhesion molecule J. Cell Biol. 114 1991 1059 1068 (Pubitemid 21909867)
26. V.K. Mohan Recombinant human epidermal growth factor (REGEN-D 150): effect on healing of diabetic foot ulcers Diab. Res. Clin. Pract. 78 2007 405 411 (Pubitemid 350047511)
27. K. Breuing, C. Andree, G. Helo, J. Slama, P.Y. Liu, and E. Ericksson Growth factors in the repair of partial thickness porcine skin wounds Plast. Reconstr. Surg. 100 1997 657 664 (Pubitemid 27381071)
28. J.A. Bauer, W. Rao, and D.J. Smith Evaluation of linear polyethyleneimine/nitric oxide adduct on wound repair: therapy versus toxicity Wound Rep. Regen. 6 1998 569 577 (Pubitemid 128659204)
29. Y. Kunugiza, N. Tomita, T. Tomita, H. Hashimoto, K. Yamasaki, H. Koike, H. Yoshikawa, and R. Morishita Effective acceleration of wound healing by simultaneous transfection of hepatocyte growth factor gene and prostacyclin synthase gene using Shima Jet Mol. Ther. 9 2004 S397
30. N.L. Occleston, D. Fairlamb, J. Hutchison, S. O'Kane, and M.W.J. Ferguson Avotermin for the improvement of scar appearance: a new pharmaceutical in a new therapeutic area Exp. Op. Invest. Drugs 18 2009 1231 1239
31. C. Alemdaroĝlu, Z. Deĝim, N. Celebi, M. Şengezer, M. Alömeroglu, and A. Nacar Investigation of epidermal growth factor containing liposome formulation effects on burn wound healing J. Biomed. Mater. Res. A 85 2008 271 283 (Pubitemid 351355377)
32. H. Lee, and T.G. Park Preparation and characterization of mono-PEGylated epidermal growth factor: evaluation of in vitro biologic activity Pharm. Res. 19 2002 845 851 (Pubitemid 34686745)
33. D.H. Na, Y.S. Youn, I.B. Lee, E.J. Park, C.J. Park, and K.C. Lee Effect of molecular size of pegylated recombinant human epidermal growth factor on the biological activity and stability in rat wound tissue Pharm. Dev. Technol. 11 2006 513 519 (Pubitemid 44852433)
34. A. Schneider, J.A. Garlick, and C. Egles Self-assembling peptide nanofiber scaffolds accelerate wound healing PLoS ONE 3 2008 e1410
35. J.S. Choi, K.W. Leong, and H.S. Yoo in vivo wound healing of diabetic ulcers using electrospun nanofibers immobilized with human epidermal growth factor (EGF) Biomaterials 29 2008 587 596 (Pubitemid 350100803)
36. R. Duncan The dawning era of polymer therapeutics Nat. Rev. Drug Disc. 2 2003 347 360 (Pubitemid 37361705)
37. S. Barrientos, O. Stojadinovic, M.S. Golinko, H. Brem, and M. Tomic-Canic Growth factors and cytokines in wound healing Wound Rep. Regen. 16 2008 585 601
38. A. Tanaka, T. Nagate, and H. Matsuda Acceleration of wound healing by gelatin film dressings with epidermal growth factor J. Vet. Med. Sci. 67 2005 909 913 (Pubitemid 41436280)
39. C. Alemdaroĝlu, Z. Deǧim, N. Celebi, F. Zor, S. Oztürk, and D. Erdoĝan An investigation on burn wound healing in rats with chitosan gel formulation containing epidermal growth factor Burns 32 2006 319 327
40. W.H. Lai, P.H. Cameron, I. Wada, J. Doherty, D.G. Kay, B.I. Posner, and J.J.M. Bergeron Ligand-mediated internalization, recycling and downregulation of the epidermal growth factor receptor in vivo J. Cell Biol. 109 1989 2741 2749 (Pubitemid 20011901)
41. H.N.E. Stevens, and G.M. Eccleston Wound healing dressings and drug delivery systems: a review J. Pharm. Sci. 97 2008 2892 2923
42. E.K. Le Grand Preclinical promise of becaplermin (rhPDGF-BB) in wound healing Am. J. Surg. 176 1998 48S 54S (Pubitemid 28460657)